Global Continuous Blood Glucose Monitoring Market - By Size, Share Analysis, Growth Trends And Forecasts 2024-2033
Overview and Scope
A continuous blood glucose
monitoring device enables a person to better regulate glucose levels throughout
the day and experience fewer low blood glucose situations.
Sizing and Forecast
The continous blood glucose
monitoring market size has grown rapidly in recent years. It will grow from
$8.09 billion in 2023 to $9.68 billion in 2024 at a compound annual growth
rate (CAGR) of 19.7%. The growth in the historic period can be
attributed to increase in diabetes prevalence, regulatory compliance, demand
for remote monitoring, emerging markets, rise in healthcare spending.
The continous blood glucose
monitoring market size is expected to see exponential growth in the next few
years. It will grow to $20.44 billion in
2028 at a compound annual growth rate (CAGR) of 20.5%. The growth in the forecast period can be
attributed to growing aging population, rising home healthcare, telehealth
expansion, rise in healthcare expenditure, rise in disposable income. Major
trends in the forecast period include wearable integration, artificial
intelligence and machine learning, advanced sensors and accuracy, partnerships
and collaboration.
To access more details
regarding this report, visit the link:
Segmentation & Regional
Insights
The continous blood glucose
monitoring market covered in this report is segmented –
1) By Component: Insulin
Pumps, Sensors, Transmitters, Receivers
2) By Application: Type 1
Diabetic Patients, Type 2 Diabetic Patients, Gestational Diabetes, Critical
Care Patients
3) By End User: Hospitals,
Homecare Diagnostics, Other End Users
Top Major Players
Roche
LifeScan Inc.
Medtronic
Abbott
GlySens Inc.
North America was the largest
region in the continuous blood glucose monitoring market in 2023. The regions
covered in the continous blood glucose monitoring market report include
Asia-Pacific, Western Europe, Eastern Europe, North America, South America,
Middle East and Africa.
Intrigued to explore the
contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13079&type=smp
Major Driver Impacting Market
Growth
The increase in the prevalence of
diabetes is expected to propel the growth of the continuous blood glucose
monitoring market going forward. Diabetes is a health disease that occurs when
the blood glucose levels fluctuate in the body. Blood glucose monitoring
devices can aid in the detection of trends and patterns that give a better full
picture of a diabetic's condition. For instance, in July 2021 the International
Diabetes Federation (IDF), a Germany-based umbrella organization of over 240
national diabetes associations stated in its IDF Diabetes Atlas 10th edition
that the estimated global population of individuals living with diabetes is
expected to increase to 643 million by 2030 and further to 783 million by 2045,
up from approximately 537 million adults aged 20 to 79 living with diabetes in
the year 2021. Therefore, the increasing prevalence of diabetes is driving the
continuous blood glucose monitoring market growth going forward.
Key Industry Players
Major companies operating in the
continous blood glucose monitoring market include F. Hoffmann-La Roche Ltd., Lifescan Inc.,
Medtronic plc., Abbott Laboratories, GlySens Inc., Arkray, Senseonics Holdings
Inc., Glysure Limited, Nemaura Medical Inc., Tandem Diabetes Care Inc.,
Goldsite Diagnostics Inc., AgaMatrix Inc., B. Braun Melsungen AG, Ypsomed
Holding AG, Terumo Corporation, Orsense Ltd., Dexcom Inc., A. Menarini
Diagnostics, Echo Therapeutics Inc., Johnson & Johnson Services Inc.,
Ascensia Diabetes Care Holdings AG, Insulet Corporation, Medtrum Technologies
Inc., Texas Instruments Inc., Beta Bionics Inc., Bigfoot Biomedical Inc., One
Drop Inc., DarioHealth Corp., MedAngel BV, GluSense Ltd., PKvitality,
Nemotecnia S.A.
The continous blood glucose
monitoring market report table of
contents includes:
1. Executive Summary
2. Continuous Blood Glucose
Monitoring Market Characteristics
3. Continuous Blood Glucose
Monitoring Market Trends And Strategies
4. Continuous Blood Glucose
Monitoring Market - Macro Economic Scenario
5. Global Continuous Blood Glucose
Monitoring Market Size and Growth
...............................
31. Global Continuous Blood
Glucose Monitoring Market Competitive Benchmarking
32. Global Continuous Blood
Glucose Monitoring Market Competitive Dashboard
33. Key Mergers And Acquisitions
In The Continuous Blood Glucose Monitoring Market
34. Continuous Blood Glucose
Monitoring Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment